Reaction Details Report a problem with these data
Target
Tyrosine-protein kinase JAK3 [795-1124]
Ligand
BDBM458851
Substrate
n/a
Meas. Tech.
In Vitro JAK kinase Assays
IC50
4.00±n/a nM
Citation
 Esteve Trias, C; Taltavull Moll, J; Gonzalez Rodriguez, J; Vidal Juan, B 2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors US Patent  US10759793 Publication Date 9/1/2020 
Target
Name:
Tyrosine-protein kinase JAK3 [795-1124]
Synonyms:
JAK3 | JAK3_HUMAN | Tyrosine-protein kinase JAK3 (795-1124)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
37299.74
Organism:
Homo sapiens (Human)
Description:
aa 795-1124
Residue:
330
Sequence:
ALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS
  
Inhibitor
Name:
BDBM458851
Synonyms:
US10759793, Example 4
Type:
Small organic molecule
Emp. Form.:
C26H33FN8
Mol. Mass.:
476.5922
SMILES:
CN(C)C1CCN(CC1)c1nc(nc(N[C@H]2CC[C@H](CC#N)CC2)c1F)-c1cnn2ccccc12 |r,wU:18.19,wD:15.15,(-9.78,3.33,;-8.75,4.47,;-9.23,5.94,;-7.25,4.15,;-6.21,5.3,;-4.71,4.98,;-4.23,3.51,;-5.26,2.37,;-6.77,2.69,;-2.73,3.19,;-2.25,1.73,;-.74,1.41,;.29,2.55,;-.19,4.02,;.84,5.16,;2.35,4.84,;2.82,3.38,;4.33,3.06,;5.36,4.2,;6.87,3.88,;7.9,5.02,;8.93,6.17,;4.88,5.67,;3.38,5.99,;-1.7,4.34,;-2.17,5.8,;-.27,-.06,;-1.17,-1.3,;-.27,-2.55,;1.2,-2.07,;2.53,-2.84,;3.86,-2.07,;3.86,-.53,;2.53,.24,;1.2,-.53,)|
Structure:
Search PDB for entries with ligand similarity: